Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Johnson & Johnson
  6. Consensus
    JNJ   US4781601046

JOHNSON & JOHNSON

(JNJ)
  Report
Real-time Estimate Cboe BZX  -  12:42 2022-07-06 pm EDT
177.76 USD   -0.21%
07/01DOJ Says J&J Talc Bankruptcy Violates Congressional Mass Tort Rules
DJ
07/01Pharmaceutical companies still have the upper hand
06/30Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for the Treatment of Relapsed or Refractory Multiple Myeloma
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on JOHNSON & JOHNSON
Target Price consensus revisions : last 18 months
Recommendations (Chart) JOHNSON & JOHNSON
Analyst Recommendations on JOHNSON & JOHNSON
06/22Daiwa Securities Starts Johnson & Johnson at Outperform With $180 Price Target
MT
06/22ANALYST RECOMMENDATIONS : Johnson & Johnson, NatWest, Home Depot, Kraft Heinz, Vodafone...
05/17Citigroup Adjusts Price Target on Johnson & Johnson to $205 From $210, Reiterates Buy Rati..
MT
04/20Credit Suisse Raises Johnson & Johnson's PT to $205 from $200 After Q1 Results Top Estimat..
MT
04/20Raymond James Adjusts Price Target on Johnson & Johnson to $196 From $195, Keeps Outperfor..
MT
04/20Citigroup Adjusts Johnson & Johnson's Price Target to $210 From $203, Reiterates Buy Ratin..
MT
04/14Raymond James Adjusts Johnson & Johnson's Price Target to $195 from $185, Keeps Outperform..
MT
More recommendations
Analysis
Pharmaceutical companies still have the upper hand
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 178,14 $
Average target price 187,28 $
Spread / Average Target 5,13%
High Price Target 215,00 $
Spread / Highest target 20,7%
Low Price Target 167,00 $
Spread / Lowest Target -6,25%
Consensus detail
Consensus revision (last 18 months)